ESCC	esophageal squamous cell carcinoma
MLR	monocyte-to-lymphocyte ratio
PD-1	programmed death-1
PD-L1	programmed death ligand-1
OS	overall survival
PFS	progression free survival
C-index	concordance index
timeROC	time-dependent receiver operating characteristic
PS score	performance status score
BMI	body mass index
AUC	area under ROC curve
TNM	tumor-node-metastasis
ICI	immune checkpoint inhibitor
TMB	tumor mutational burden
ctDNA	circulating tumor DNA
NLR	neutrophil-to-lymphocyte ratio
NSCLC	non-small-cell lung cancer
GC	gastric cancer
AJCC	American Joint Committee on Cancer
ECOG	Eastern Cooperative Oncology Group
HB	hemoglobin
Nab-PTX	albumin-bound paclitaxel
PTX	paclitaxel
5-FU	fluorouracil
CR	complete response
PR	partial response
SD	stable disease
PD	progressive disease
ORR	objective remission rate
DCR	disease control rate
HR	hazard ratio
CI	confidential interval
CRC	colorectal cancer
TTP	time to progression
HCC	hepatocellular carcinoma
TILs	tumor-infiltrating lymphocytes
TAMs	tumor-associated macrophages